Literature DB >> 8811674

Spiral CT of intracranial aneurysms: correlation with digital subtraction and magnetic resonance angiography.

G Wilms1, M Guffens, S Gryspeerdt, H Bosmans, M Maaly, T Boulanger, L Van Hoe, G Marchal, A Baert.   

Abstract

Spiral CT and magnetic resonance angiography (MRA) were performed in ten patients with 14 intracranial aneurysms known from conventional angiography. All lesions, the smallest 3 mm in diameter, were visible on spiral CT and MRA. The neck of the aneurysm and its anatomical relations could very accurately be determined in all cases. Advantages of spiral CT over MRA are: a short acquisition time with reduction of motion artefacts, no dependence on flow rate or cardiac output, and excellent visualisation of calcification, thrombus and bony landmarks. Disadvantages are the necessity for iodinated contrast medium, long postprocessing and reconstruction time and the possibility of overlap of bone and venous blood.

Entities:  

Mesh:

Year:  1996        PMID: 8811674     DOI: 10.1007/bf02278113

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  14 in total

1.  CT angiography with spiral CT and maximum intensity projection.

Authors:  S Napel; M P Marks; G D Rubin; M D Dake; C H McDonnell; S M Song; D R Enzmann; R B Jeffrey
Journal:  Radiology       Date:  1992-11       Impact factor: 11.105

Review 2.  MR procedures and biomedical implants, materials, and devices: 1993 update.

Authors:  F G Shellock; S Morisoli; E Kanal
Journal:  Radiology       Date:  1993-11       Impact factor: 11.105

Review 3.  Spiral (helical) CT.

Authors:  J P Heiken; J A Brink; M W Vannier
Journal:  Radiology       Date:  1993-12       Impact factor: 11.105

4.  Mechanism of growth and rupture in cerebral berry aneurysms.

Authors:  M R Crompton
Journal:  Br Med J       Date:  1966-05-07

5.  Cerebral aneurysms: detection and delineation using 3-D-CT angiography.

Authors:  S Aoki; Y Sasaki; T Machida; T Ohkubo; M Minami; Y Sasaki
Journal:  AJNR Am J Neuroradiol       Date:  1992 Jul-Aug       Impact factor: 3.825

6.  Magnetic resonance angiography of intracranial aneurysms: comparison with intra-arterial digital subtraction angiography.

Authors:  G Schuierer; W J Huk; G Laub
Journal:  Neuroradiology       Date:  1992       Impact factor: 2.804

7.  Magnetic resonance angiography compared to intra-arterial digital subtraction angiography in patients with subarachnoid haemorrhage.

Authors:  A Gouliamos; E Gotsis; L Vlahos; C Samara; E Kapsalaki; D Rologis; Z Kapsalakis; C Papavasiliou
Journal:  Neuroradiology       Date:  1992       Impact factor: 2.804

8.  Intracranial MR angiography: application of magnetization transfer contrast and fat saturation to short gradient-echo, velocity-compensated sequences.

Authors:  W Lin; J A Tkach; E M Haacke; T J Masaryk
Journal:  Radiology       Date:  1993-03       Impact factor: 11.105

9.  Evaluation of cerebral aneurysms with helical CT: correlation with conventional angiography and MR angiography.

Authors:  R B Schwartz; H M Tice; S M Hooten; L Hsu; P E Stieg
Journal:  Radiology       Date:  1994-09       Impact factor: 11.105

10.  Blinded prospective evaluation of sensitivity of MR angiography to known intracranial aneurysms: importance of aneurysm size.

Authors:  J Huston; D A Nichols; P H Luetmer; J T Goodwin; F B Meyer; D O Wiebers; A L Weaver
Journal:  AJNR Am J Neuroradiol       Date:  1994-10       Impact factor: 3.825

View more
  2 in total

1.  Contrast-enhanced three-dimensional transcranial color-coded sonography of intracranial stenoses.

Authors:  Christof Klötzsch; Alessandro Bozzato; Gero Lammers; Michael Mull; Johannes Noth
Journal:  AJNR Am J Neuroradiol       Date:  2002-02       Impact factor: 3.825

2.  Multislice CT angiography in the selection of patients with ruptured intracranial aneurysms suitable for clipping or coiling.

Authors:  H E Westerlaan; J Gravendeel; D Fiore; J D M Metzemaekers; R J M Groen; J J A Mooij; M Oudkerk
Journal:  Neuroradiology       Date:  2007-09-22       Impact factor: 2.804

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.